MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avient Corporation Common Stock (NY:AVNT)

32.07 +0.54 (+1.71%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 537,932
Open 31.40
Bid (Size) 31.53 (1)
Ask (Size) 32.61 (1)
Prev. Close 31.53
Today's Range 30.81 - 32.22
52wk Range 27.86 - 54.68
Shares Outstanding 91,297,358
Dividend Yield 3.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Price Over Earnings Overview: Avient
 
Via Benzinga
This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga

Performance

YTD
-20.3%
-20.3%
1 Month
+0.1%
+0.1%
3 Month
-5.1%
-5.1%
6 Month
-6.2%
-6.2%
1 Year
-31.2%
-31.2%

More News

Read More
A Congress Member Bought Up To $615K In LandBridge Stock: Here's What You Need To Know
Via Benzinga
Earnings Summary on Avient
Via The Motley Fool
Topics World Trade
Avient Corp (NYSE:AVNT) Q2 2025 Earnings: Revenue Slightly Misses Estimates, EPS Matches Forecasts
Via Chartmill
What's Next: Avient's Earnings Preview
Via Benzinga
How Is The Market Feeling About Avient?
Via Benzinga
Is Avient Gaining or Losing Market Support?
Via Benzinga
Earnings Scheduled For August 1, 2025
Via Benzinga
Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting
Via Benzinga
Topics Cannabis
Earnings Scheduled For May 6, 2025
Via Benzinga
Is Avient Gaining or Losing Market Support?
Via Benzinga
4 Analysts Assess Avient: What You Need To Know
Via Benzinga
What Analysts Are Saying About Avient Stock
Via Benzinga
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
Avient Stock: Manufacturing Play With Double-Digit Upside
Via MarketBeat
AVNT Stock Earnings: Avient Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Eastman Chemical Stock Sees IBD RS Rating Climb To 77
Via Investor's Business Daily
Critical Insights From Avient Analyst Ratings: What You Need To Know
Via Benzinga
Earnings Scheduled For February 14, 2024
Via Benzinga
International Expansion Still Major Growth Driver For Canadian Cannabis Co. Avant, Reports 4% YoY Increase In Q2 Net Revenue
Via Benzinga
Topics Cannabis
AVNT Stock Earnings: Avient Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
International Expansion Drives Growth For This Canadian Cannabis Producer As It Reports Record Q1 Revenue
Via Benzinga
Topics Cannabis
DraftKings To Rally Over 48%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga

Frequently Asked Questions

Is Avient Corporation Common Stock publicly traded?
Yes, Avient Corporation Common Stock is publicly traded.
What exchange does Avient Corporation Common Stock trade on?
Avient Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Avient Corporation Common Stock?
The ticker symbol for Avient Corporation Common Stock is AVNT on the New York Stock Exchange
What is the current price of Avient Corporation Common Stock?
The current price of Avient Corporation Common Stock is 32.07
When was Avient Corporation Common Stock last traded?
The last trade of Avient Corporation Common Stock was at 10/31/25 07:00 PM ET
What is the market capitalization of Avient Corporation Common Stock?
The market capitalization of Avient Corporation Common Stock is 2.93B
How many shares of Avient Corporation Common Stock are outstanding?
Avient Corporation Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story